Health
‘Potent’ neutralizing antibody studies and what they could mean for a coronavirus treatment | TheHill – The Hill
Although it would need to be tested in clinical trials, monoclonal antibodies can bind to the coronavirus and may prevent severe illness.
Were finding out more about the coronavirus and COVID-19 every week, and lately there have been reports that fewer people than expected may develop antibodies to the virus after infection. Experts are still hopeful that synthetic antibodies may one day be used as a therapeutic for the coronavirus.
A study recently published in Nature identifies a mix of 19 different antibodies that target SARS-CoV-2, the coronavirus that causes COVID-19. Several studies like this have been published since the s…
Continue Reading
